F.D.A. Confirms Widespread Shortages of Adderall

October 13, 2022

(New York Times) – The Food and Drug Administration has declared a nationwide shortage of Adderall, a medication used to treat A.D.H.D. that has had surging demand in recent years. The F.D.A. noted that one maker of the drug, Teva Pharmaceuticals, has had continuing manufacturing delays, and other manufacturers of generic versions or alternatives have also reported periodic problems with meeting demand. The agency recommended that patients taking Adderall talk to their doctors to find alternative treatments. (Read More)